Skip to Main Content

Center for Outcomes Research & Evaluation

alt text

The Center for Outcomes Research & Evaluation (CORE) is a leading national outcomes research center working on select projects designed to assess healthcare quality and evaluate clinical decision making and comparative effectiveness of specific healthcare interventions. Our mission is to improve health and health care through targeted research and evaluation projects that combine scholarship and service to have a positive impact on policy and people’s lives.

The Center for Outcomes Research and Evaluation (CORE) is dedicated to applying scientific methods and developing scientific approaches to address the clinical and healthcare policy challenges that face our country and the global community.

CORE In the News

Yahoo! money – May 2020
“Moderna COVID-19 vaccine data is ‘baby-step” in right direction: Expert”

Washington Post – May 2020
“Elderly covid-19 patients on ventilators usually do not survive, New York hospitals report”

Valdosta Daily Times – May 2020
“Study Finds Seniors with COVID-19 Taking Hypertension Medication at Lower Risk of Hospitalization, Clinical Trial to Follow Immediately”

Medscape – May 2020
“ACE Inhibitors Protective Against Severe COVID-19?”

The Washington Post – May 2020
“An easier coronavirus test is within spitting distance”

Watertown Public Opinion – May 2020
“Study Finds Seniors with COVID-19 Taking Hypertension Medication at Lower Risk of Hospitalization, Clinical Trial to Follow Immediately”

Wall Street Reporter – May 2020
“Moderna COVID-19 vaccine data is ‘baby-step’ in right direction: Professor of Medicine at Yale”

Medscape Medical News – May 2020
“Racially Segregated Neighborhoods Bad for the Brain?”

MedPage Today (blog) – May 2020
“Does Peer Review Still Matter in the Era of COVID-19?”

Orlando Sentinel – May 2020
“Who should get tested for coronavirus? Floridians get mixed messages”

Health Afffairs Blog – May 2020
“New Federal Rules Pave The Way For Patient-Driven Health Information Exchange And Real-World Evidence On COVID-19 Surveillance And Treatment”

POLITICO – Health - May 2020
“Why one breakthrough drug won’t end the pandemic – Five reasons to be cautious about remdesivir.”